Pharmacognosy intro
When digestion is off and sleep is fitful, chamomile is the herb most people already know. That familiarity is earned. It is one of the oldest documented medicinal plants, with over 120 identified secondary metabolites and clinical evidence spanning anxiety, sleep, and inflammation. A meta-analysis of 12 randomized controlled trials (965 patients) found significant improvement in sleep quality scores, and meaningful anxiety reduction on the HAM-A scale within two weeks of daily use. Clinical trials have used standardized extracts at 500 mg three times daily for periods up to 26 weeks with mild adverse events comparable to placebo. The primary anxiolytic compound, apigenin, binds the benzodiazepine site on GABA-A receptors but acts as a partial agonist. That means calming without full sedation or the dependence risk of pharmaceutical benzodiazepines. German chamomile produces chamazulene during steam distillation, a COX-2 and 5-LOX inhibitor responsible for the deep blue oil color and the anti-inflammatory reputation. Used across Egyptian, European, Ayurvedic, and Chinese medical systems for millennia. People with Asteraceae allergies (ragweed, chrysanthemum) should exercise caution. May potentiate anticoagulants due to coumarin content.